Wealthspring Capital LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealthspring Capital LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$1,306,000
+1.3%
130,290
+0.2%
0.26%
+6.6%
Q2 2022$1,289,000
-5.6%
130,072
-6.0%
0.24%
-9.7%
Q1 2022$1,365,000
+9.4%
138,373
+10.6%
0.27%0.0%
Q4 2021$1,248,000
+0.2%
125,064
-0.5%
0.27%
-11.0%
Q3 2021$1,246,000
+4.4%
125,700
+7.4%
0.30%
+0.7%
Q2 2021$1,194,000
+1.4%
117,0540.0%0.30%
-6.3%
Q1 2021$1,177,000
-15.0%
117,054
-9.9%
0.32%
-53.6%
Q4 2020$1,385,000129,8800.69%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2020
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,005,0001.11%
Sio Capital Management, LLC 300,000$3,004,0000.61%
Wealthspring Capital LLC 117,054$1,177,0000.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,000,000$10,012,0000.21%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,012,0000.21%
Sage Mountain Advisors LLC 95,970$965,0000.20%
BVF INC/IL 500,000$5,030,0000.19%
HealthCor Management, L.P. 334,180$3,362,0000.12%
Verition Fund Management LLC 397,692$4,056,0000.05%
Rock Springs Capital Management LP 206,000$2,063,0000.04%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders